By G HossainPosted on February 5, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic. Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq Post navigation Programmable RNA 2.0: Beyond the First mRNA RevolutionNovartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy